» Articles » PMID: 21490870

Treatment of Isolated Gastric Crohn's Disease with Inhaled Corticosteroids

Overview
Publisher Karger
Specialty Gastroenterology
Date 2011 Apr 15
PMID 21490870
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Isolated gastric Crohn's disease is unusual and a rare cause of pyloric outlet obstruction. If medical therapy is ineffective, patients may require surgery to relieve gastric outlet obstruction. Herein we describe a patient with isolated gastric Crohn's disease with pyloric outlet obstruction who was steroid-dependent and had a relapse despite receiving biologic and immunomodulatory therapy, but ultimately responded to topical treatment with inhaled corticosteroids.

Citing Articles

A Classification for Gastric Outlet Obstruction in Childhood: Extending Beyond Infantile Hypertrophic Pyloric Stenosis.

Gurkan O, Ozturk H, Kaya C, Gurcan Kaya N, Eksi Bozbulut N, Can A Turk J Gastroenterol. 2024; 35(3):255-261.

PMID: 39128098 PMC: 11059985. DOI: 10.5152/tjg.2024.23202.


Drug Repurposing in Crohn's Disease Using Danish Real-World Data.

Shakibfar S, Allin K, Jess T, Barbieri M, Battini V, Simoncic E Pragmat Obs Res. 2024; 15:17-29.

PMID: 38404739 PMC: 10894518. DOI: 10.2147/POR.S444569.


Crohn's disease: An enigmatic variant with gastritis and ileal obstruction.

Amo-Tachie S, Ocansey F, Yeboah A Clin Case Rep. 2024; 12(1):e8371.

PMID: 38161629 PMC: 10753134. DOI: 10.1002/ccr3.8371.


Pediatric Crohn's disease with severe morbidity manifested by gastric outlet obstruction: two cases report and review of the literature.

Kim E, Park J, Choe Y, Kim M Intest Res. 2020; 19(4):472-477.

PMID: 33108856 PMC: 8566835. DOI: 10.5217/ir.2020.00072.


Pyloric stenosis as a manifestation of isolated gastric Crohn's disease responding to intralesional steroid injection and balloon dilation: a case report.

Balendran K, Udumalagala S, Nawaraththne N J Med Case Rep. 2019; 13(1):331.

PMID: 31718712 PMC: 6852991. DOI: 10.1186/s13256-019-2272-8.


References
1.
Sandborn W . Preliminary report on the use of oral tacrolimus (FK506) in the treatment of complicated proximal small bowel and fistulizing Crohn's disease. Am J Gastroenterol. 1997; 92(5):876-9. View

2.
Matsui T, Hatakeyama S, Ikeda K, Yao T, Takenaka K, Sakurai T . Long-term outcome of endoscopic balloon dilation in obstructive gastroduodenal Crohn's disease. Endoscopy. 1997; 29(7):640-5. DOI: 10.1055/s-2007-1004271. View

3.
Grove A, Allam C, McFarlane L, McPhate G, Jackson C, Lipworth B . A comparison of the systemic bioactivity of inhaled budesonide and fluticasone propionate in normal subjects. Br J Clin Pharmacol. 1994; 38(6):527-32. PMC: 1364916. DOI: 10.1111/j.1365-2125.1994.tb04394.x. View

4.
Kamada A, Szefler S, Martin R, Boushey H, Chinchilli V, Drazen J . Issues in the use of inhaled glucocorticoids. The Asthma Clinical Research Network. Am J Respir Crit Care Med. 1996; 153(6 Pt 1):1739-48. DOI: 10.1164/ajrccm.153.6.8665030. View

5.
Feagan B, Fedorak R, Irvine E, Wild G, Sutherland L, Steinhart A . A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators. N Engl J Med. 2000; 342(22):1627-32. DOI: 10.1056/NEJM200006013422202. View